Daptomycin forms cation- and size-selective pores in model membranes

Biochimica et Biophysica Acta - Biomembranes

Volumn 1838, Issue 10, 2014, Pages 2425-2430

  Zhang, Tianhua ^a   Muraih, Jawad K ^b   MacCormick, Ben ^c   Silverman, Jared ^d   Palmer, Michael ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b AL MUTHANNA UNIVERSITY   (Iraq)

^c BioMedica Diagnostics   (Canada)

^d CUBIST PHARMACEUTICALS INC   (United States)

Author keywords

Aptomycin; Fluorescence; Lipopeptide; Membrane permeabilization; Pore formation; Pyranine

Indexed keywords

CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CATION; DAPTOMYCIN; HEXAMETHONIUM; LIPOSOME; MAGNESIUM ION; PHOSPHATIDYLGLYCEROL; POTASSIUM ION; SODIUM ION; VALINOMYCIN;

ANION TRANSPORT; ARTICLE; BACTERIAL CELL; CELL MEMBRANE DEPOLARIZATION; CELL PH; DRUG STRUCTURE; FLOW RATE; HYDRATION; MEMBRANE PERMEABILITY; MEMBRANE VESICLE; NONHUMAN; POROSITY; PRIORITY JOURNAL; SODIUM TRANSPORT;

BACTERIA (MICROORGANISMS); POSIBACTERIA;

APTOMYCIN; FLUORESCENCE; LIPOPEPTIDE; MEMBRANE PERMEABILIZATION; PORE-FORMATION; PYRANINE;

BACTERIA; CATIONS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; DAPTOMYCIN; LIPOSOMES; MEMBRANE POTENTIALS; METALS; MODELS, CHEMICAL;

EID: 84903409700     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2014.05.014     Document Type: Article

References (31)

1. B.I. Eisenstein, F.B.J. Oleson, and R.H. Baltz Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD Clin. Infect. Dis. 50 Suppl. 1 2010 S10 S15
2. F.P. Tally, and M.F. DeBruin Development of daptomycin for Gram-positive infections J. Antimicrob. Chemother. 46 2000 523 526
3. J.N. Steenbergen, J. Alder, G.M. Thorne, and F.P. Tally Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections J. Antimicrob. Chemother. 55 2005 283 288 (Pubitemid 40425449)
4. M. Debono, M. Barnhart, C.B. Carrell, J.A. Hoffmann, J.L. Occolowitz, B.J. Abbott, D.S. Fukuda, R.L. Hamill, K. Biemann, and W.C. Herlihy A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation J. Antibiot. (Tokyo) 40 1987 761 777 (Pubitemid 17086227)
5. R.H. Baltz Biosynthesis and genetic engineering of lipopeptide antibiotics related to daptomycin Curr. Top. Med. Chem. 8 2008 618 638 (Pubitemid 351982571)
6. D. Mengin-Lecreulx, N.E. Allen, J.N. Hobbs, and J. van Heijenoort Inhibition of peptidoglycan biosynthesis in Bacillus megaterium by daptomycin FEMS Microbiol. Lett. 57 1990 245 248 (Pubitemid 20207492)
7. P. Canepari, M. Boaretti, M.M. Lleó, and G. Satta Lipoteichoic acid as a new target for activity of antibiotics: mode of action of daptomycin (LY146032) Antimicrob. Agents Chemother. 34 1990 1220 1226 (Pubitemid 20177384)
8. W.E.J. Alborn, N.E. Allen, and D.A. Preston Daptomycin disrupts membrane potential in growing Staphylococcus aureus Antimicrob. Agents Chemother. 35 1991 2282 2287
9. N.E. Allen, W.E.J. Alborn, and J.N.J. Hobbs Inhibition of membrane potential-dependent amino acid transport by daptomycin Antimicrob. Agents Chemother. 35 1991 2639 2642
10. J.A. Silverman, N.G. Perlmutter, and H.M. Shapiro Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus Antimicrob. Agents Chemother. 47 2003 2538 2544 (Pubitemid 36919456)
11. E. Rubinchik, T. Schneider, M. Elliott, W.R.P. Scott, J. Pan, C. Anklin, H. Yang, D. Dugourd, A. Müller, K. Gries, S.K. Straus, H.G. Sahl, and R.E.W. Hancock Mechanism of action and limited cross-resistance of new lipopeptide MX-2401 Antimicrob. Agents Chemother. 55 2011 2743 2754
12. N. Cotroneo, R. Harris, N. Perlmutter, T. Beveridge, and J.A. Silverman Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus Antimicrob. Agents Chemother. 52 2008 2223 2225 (Pubitemid 351758562)
13. J.K. Muraih, A. Pearson, J. Silverman, and M. Palmer Oligomerization of daptomycin on membranes Biochim. Biophys. Acta 1808 2011 1154 1160
14. J.K. Muraih, and M. Palmer Estimation of the subunit stoichiometry of the membrane-associated daptomycin oligomer by FRET Biochim. Biophys. Acta 1818 2012 1642 1647
15. J.K. Muraih, J. Harris, S.D. Taylor, and M. Palmer Characterization of daptomycin oligomerization with perylene excimer fluorescence: stoichiometric binding of phosphatidylglycerol triggers oligomer formation Biochim. Biophys. Acta 1818 2012 673 678
16. T. Zhang, J.K. Muraih, E. Mintzer, N. Tishbi, C. Desert, J. Silverman, S. Taylor, and M. Palmer Mutual inhibition through hybrid oligomer formation of daptomycin and the semisynthetic lipopeptide antibiotic CB-182,462 Biochim. Biophys. Acta 1828 2013 302 308
17. R.H. Baltz Daptomycin: mechanisms of action and resistance, and biosynthetic engineering Curr. Opin. Chem. Biol. 13 2009 144 151
18. L. Friedman, J.D. Alder, and J.A. Silverman Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus Antimicrob. Agents Chemother. 50 2006 2137 2145 (Pubitemid 43807536)
19. A. Hachmann, E. Sevim, A. Gaballa, D.L. Popham, H. Antelmann, and J.D. Helmann Reduction in membrane phosphatidylglycerol content leads to daptomycin resistance in Bacillus subtilis Antimicrob. Agents Chemother. 55 2011 4326 4337
20. L.D. Mayer, M.J. Hope, and P.R. Cullis Vesicles of variable sizes produced by a rapid extrusion procedure Biochim. Biophys. Acta 858 1986 161 168
21. N.R. Clement, and J.M. Gould Pyranine (8-hydroxy-1,3,6- pyrenetrisulfonate) as a probe of internal aqueous hydrogen ion concentration in phospholipid vesicles Biochemistry 20 1981 1534 1538
22. J. Kríz, J. Dybal, and E. Makrlík Valinomycin-proton interaction in low-polarity media Biopolymers 82 2006 536 548 (Pubitemid 44126364)
23. D. Jung, J.P. Powers, S.K. Straus, and R.E.W. Hancock Lipid-specific binding of the calcium-dependent antibiotic daptomycin leads to changes in lipid polymorphism of model membranes Chem. Phys. Lipids 154 2008 120 128
24. V. Laganas, J. Alder, and J.A. Silverman In vitro bactericidal activities of daptomycin against Staphylococcus aureus and Enterococcus faecalis are not mediated by inhibition of lipoteichoic acid biosynthesis Antimicrob. Agents Chemother. 47 2003 2682 2684 (Pubitemid 36919481)
25. G.L. Ellman Tissue sulfhydryl groups Arch. Biochem. Biophys. 82 1959 70 77
26. T. Zhang, J.K. Muraih, N. Tishbi, J. Herskowitz, R.L. Victor, J. Silverman, S. Uwumarenogie, S.D. Taylor, M. Palmer, and E. Mintzer Cardiolipin prevents membrane translocation and permeabilization by daptomycin J. Biol. Chem. 289 17 Apr. 25 2014 11584 11591
27. A. Finkelstein, and O.S. Andersen The gramicidin A channel: a review of its permeability characteristics with special reference to the single-file aspect of transport J. Membr. Biol. 59 1981 155 171 (Pubitemid 11069026)
28. A.G. Volkov, S. Paula, and D.W. Deamer Two mechanisms of permeation of small neutral molecules and hydrated ions across phospholipid bilayers Bioelectrochem. Bioenerg. 42 1997 153 160 (Pubitemid 27273840)
29. B. Tansel, J. Sager, T. Rector, J. Garland, R.F. Strayer, L. Levine, M. Roberts, M. Hummerick, and J. Bauer Significance of hydrated radius and hydration shells on ionic permeability during nanofiltration in dead end and cross flow modes Sep. Purif. Technol. 51 2006 40 47 (Pubitemid 44164373)
30. E.V. Anslyn, and D.A. Dougherty Modern Physical Organic Chemistry 2006 University Science Books (Edition)
31. C. Mascio, K. Townsend, N. Cotroneo, and J. Silverman Microbiological Characterization of a Novel Lipopeptide Antibiotic With Activity in Pulmonary Surfactant 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 12-15, 2009, San Francisco, CA, American Society For Microbiology, Washington, DC 2009